Logo image of NL.CA

NORTHERN LION GOLD CORP (NL.CA) Stock Fundamental Analysis

TSX-V:NL - TSX Venture Exchange - CA6653783036 - Common Stock - Currency: CAD

0.16  +0.01 (+6.67%)

Fundamental Rating

0

NL gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. NL has a bad profitability rating. Also its financial health evaluation is rather negative. NL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NL had negative earnings in the past year.
NL.CA Yearly Net Income VS EBIT VS OCF VS FCFNL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -100K -200K -300K -400K -500K

1.2 Ratios

The Return On Assets of NL (-67.31%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -67.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NL.CA Yearly ROA, ROE, ROICNL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -2K -4K -6K -8K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NL.CA Yearly Profit, Operating, Gross MarginsNL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, NL has about the same amount of shares outstanding.
There is no outstanding debt for NL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NL.CA Yearly Shares OutstandingNL.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
NL.CA Yearly Total Debt VS Total AssetsNL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200K 400K 600K 800K 1M

2.2 Solvency

Based on the Altman-Z score of -59.81, we must say that NL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -59.81, NL is doing worse than 88.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -59.81
ROIC/WACCN/A
WACCN/A
NL.CA Yearly LT Debt VS Equity VS FCFNL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 200K 400K

2.3 Liquidity

NL has a Current Ratio of 0.95. This is a bad value and indicates that NL is not financially healthy enough and could expect problems in meeting its short term obligations.
NL has a Current ratio of 0.95. This is in the lower half of the industry: NL underperforms 64.32% of its industry peers.
NL has a Quick Ratio of 0.95. This is a bad value and indicates that NL is not financially healthy enough and could expect problems in meeting its short term obligations.
NL's Quick ratio of 0.95 is on the low side compared to the rest of the industry. NL is outperformed by 61.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
NL.CA Yearly Current Assets VS Current LiabilitesNL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

NL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -147.20%.
EPS 1Y (TTM)-147.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NL.CA Yearly Revenue VS EstimatesNL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
NL.CA Yearly EPS VS EstimatesNL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NL.CA Price Earnings VS Forward Price EarningsNL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NL.CA Per share dataNL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01 -0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORTHERN LION GOLD CORP

TSX-V:NL (3/5/2025, 7:00:00 PM)

0.16

+0.01 (+6.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners23.21%
Ins Owner ChangeN/A
Market Cap2.18M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z -59.81
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.4%
OCF growth 3YN/A
OCF growth 5YN/A